OXI Share Price

Open 0.16 Change Price %
High 0.17 1 Day 0.00 0.00
Low 0.16 1 Week 0.03 21.43
Close 0.17 1 Month -0.01 -5.56
Volume 3949 1 Year 0.15 750.00
52 Week High 2.97
52 Week Low 0.01
OXI Important Levels
Resistance 2 0.18
Resistance 1 0.18
Pivot 0.17
Support 1 0.16
Support 2 0.16
EPA France Most Active Stocks
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
GSZ 17.56 3.97%
GSZ 17.56 3.97%
GSZ 17.56 3.97%
ALALO 0.04 33.33%
ACA 10.84 2.26%
More..
EPA France Top Gainers Stocks
ALALO 0.04 33.33%
ALFRE 1.20 18.81%
APAM 33.78 15.72%
APAM 33.78 15.72%
MLLOI 3.80 15.15%
DEXB 17.47 13.89%
DEXB 17.47 13.89%
ALVER 1.10 13.40%
MT 4.53 12.97%
MT 4.53 12.97%
More..
EPA France Top Losers Stocks
VRNL 0.59 -26.25%
CIB 0.08 -11.11%
CIB 0.08 -11.11%
CIB 0.08 -11.11%
CIB 0.08 -11.11%
ALMAS 0.81 -10.00%
ALMGI 1.45 -9.38%
THER 32.00 -8.23%
THER 32.00 -8.23%
EPCP 650.00 -7.14%
More..

Oxis International Inc (EPA: OXI)

OXI Technical Analysis 5
As on 5th Dec 2016 OXI Share Price closed @ 0.17 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.32 & Strong Sell for SHORT-TERM with Stoploss of 0.27 we also expect STOCK to react on Following IMPORTANT LEVELS.
OXI Target for December
1st Target up-side 0.2
2nd Target up-side 0.23
3rd Target up-side 0.26
1st Target down-side 0.12
2nd Target down-side 0.09
3rd Target down-side 0.06
OXI Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.oxis.com
OXI Address
OXI
468 North Camden Drive
2nd Floor
Beverly Hills, CA 90210
United States
Phone: 310-860-5184
Interactive Technical Analysis Chart Oxis International Inc ( OXI EPA France )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Oxis International Inc
OXI Business Profile
Oxis International, Inc. engages in the research, development, and sale of pharmaceutical products for the treatment of oxidative stress and inflammation. Its finished product and finished product candidates include therapeutic nutraceutical products, cosmeceutical products, functionals foods, and functional beverages. The company also provides proprietary compounds and formulations to biotech and pharmaceutical companies as drug candidates; EGT, a dietary supplement; and ErgoFlex, dietary supplement for the treatment of joint pain and restricted mobility. In addition, it offers personal care products, including skin care and cosmetic products; and veterinary products for companion animals, livestock, and performance animals, such as race horses. The company owns a range of trademarks, including ErgoFlex, Ergo-Plex, ERGOLD, Ergo-Max, Ergo-Pur, V[eye]tamin, and Immortal Energy, as well as a non-EGT related trademark Palosein. Oxis International, Inc. was founded in 1965 and is based in Beverly Hills, California.